vs

Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and Target Hospitality Corp. (TH). Click either name above to swap in a different company.

Bioceres Crop Solutions Corp. is the larger business by last-quarter revenue ($77.6M vs $73.5M, roughly 1.1× Target Hospitality Corp.). Bioceres Crop Solutions Corp. runs the higher net margin — -9.6% vs -20.3%, a 10.7% gap on every dollar of revenue. On growth, Target Hospitality Corp. posted the faster year-over-year revenue change (22.0% vs -16.8%). Over the past eight quarters, Target Hospitality Corp.'s revenue compounded faster (0.7% CAGR vs -8.4%).

Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.

Target Hospitality is a company that provides workforce lodging and other temporary, modular housing used for oil, gas and mining operations; large-scale events; and disaster relief. Target Hospitality is based in The Woodlands, Texas, and also has offices in Williston, North Dakota; Denver, Colorado; Calgary, Alberta.

BIOX vs TH — Head-to-Head

Bigger by revenue
BIOX
BIOX
1.1× larger
BIOX
$77.6M
$73.5M
TH
Growing faster (revenue YoY)
TH
TH
+38.8% gap
TH
22.0%
-16.8%
BIOX
Higher net margin
BIOX
BIOX
10.7% more per $
BIOX
-9.6%
-20.3%
TH
Faster 2-yr revenue CAGR
TH
TH
Annualised
TH
0.7%
-8.4%
BIOX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BIOX
BIOX
TH
TH
Revenue
$77.6M
$73.5M
Net Profit
$-7.4M
$-14.9M
Gross Margin
46.8%
9.6%
Operating Margin
9.3%
-22.9%
Net Margin
-9.6%
-20.3%
Revenue YoY
-16.8%
22.0%
Net Profit YoY
-20.2%
-219.1%
EPS (diluted)
$-0.12
$-0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BIOX
BIOX
TH
TH
Q4 25
$73.5M
Q3 25
$77.6M
$91.6M
Q2 25
$54.9M
Q1 25
$60.6M
$54.9M
Q4 24
$98.8M
$60.2M
Q3 24
$93.3M
$65.8M
Q2 24
$67.5M
Q1 24
$84.0M
$72.4M
Net Profit
BIOX
BIOX
TH
TH
Q4 25
$-14.9M
Q3 25
$-7.4M
$-795.0K
Q2 25
$-14.9M
Q1 25
$-1.6M
$-6.5M
Q4 24
$605.2K
$12.5M
Q3 24
$-6.2M
$20.0M
Q2 24
$18.4M
Q1 24
$9.8M
$20.4M
Gross Margin
BIOX
BIOX
TH
TH
Q4 25
9.6%
Q3 25
46.8%
19.6%
Q2 25
-0.6%
Q1 25
39.4%
32.7%
Q4 24
42.0%
61.5%
Q3 24
40.2%
68.7%
Q2 24
69.4%
Q1 24
50.8%
67.8%
Operating Margin
BIOX
BIOX
TH
TH
Q4 25
-22.9%
Q3 25
9.3%
0.1%
Q2 25
-30.8%
Q1 25
1.5%
-2.0%
Q4 24
14.5%
34.5%
Q3 24
2.5%
42.5%
Q2 24
43.8%
Q1 24
15.7%
42.0%
Net Margin
BIOX
BIOX
TH
TH
Q4 25
-20.3%
Q3 25
-9.6%
-0.9%
Q2 25
-27.2%
Q1 25
-2.6%
-11.8%
Q4 24
0.6%
20.8%
Q3 24
-6.6%
30.4%
Q2 24
27.2%
Q1 24
11.6%
28.2%
EPS (diluted)
BIOX
BIOX
TH
TH
Q4 25
$-0.14
Q3 25
$-0.12
$-0.01
Q2 25
$-0.15
Q1 25
$-0.02
$-0.07
Q4 24
$0.00
$0.12
Q3 24
$-0.10
$0.20
Q2 24
$0.18
Q1 24
$0.14
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BIOX
BIOX
TH
TH
Cash + ST InvestmentsLiquidity on hand
$15.5M
$8.3M
Total DebtLower is stronger
$1.7M
Stockholders' EquityBook value
$288.3M
$389.3M
Total Assets
$734.9M
$530.2M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BIOX
BIOX
TH
TH
Q4 25
$8.3M
Q3 25
$15.5M
$30.4M
Q2 25
$19.2M
Q1 25
$38.5M
$34.5M
Q4 24
$29.2M
$190.7M
Q3 24
$32.3M
$177.7M
Q2 24
$154.3M
Q1 24
$16.4M
$124.3M
Total Debt
BIOX
BIOX
TH
TH
Q4 25
$1.7M
Q3 25
$2.0M
Q2 25
$26.3M
Q1 25
$42.9M
Q4 24
$1.5M
Q3 24
$994.0K
Q2 24
$1.1M
Q1 24
$179.9M
Stockholders' Equity
BIOX
BIOX
TH
TH
Q4 25
$389.3M
Q3 25
$288.3M
$402.4M
Q2 25
$401.3M
Q1 25
$345.0M
$415.3M
Q4 24
$346.3M
$421.1M
Q3 24
$346.0M
$417.6M
Q2 24
$397.2M
Q1 24
$348.5M
$375.5M
Total Assets
BIOX
BIOX
TH
TH
Q4 25
$530.2M
Q3 25
$734.9M
$541.2M
Q2 25
$533.7M
Q1 25
$798.2M
$562.5M
Q4 24
$835.2M
$725.8M
Q3 24
$827.3M
$709.8M
Q2 24
$697.0M
Q1 24
$836.1M
$687.2M
Debt / Equity
BIOX
BIOX
TH
TH
Q4 25
0.00×
Q3 25
0.01×
Q2 25
0.07×
Q1 25
0.10×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.48×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BIOX
BIOX
TH
TH
Operating Cash FlowLast quarter
$14.4M
$5.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BIOX
BIOX
TH
TH
Q4 25
$5.7M
Q3 25
$14.4M
$53.4M
Q2 25
$11.1M
Q1 25
$23.3M
$3.9M
Q4 24
$-5.4M
$30.6M
Q3 24
$5.2M
$31.4M
Q2 24
$39.1M
Q1 24
$-17.4M
$50.6M
Free Cash Flow
BIOX
BIOX
TH
TH
Q4 25
Q3 25
Q2 25
Q1 25
$-11.6M
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
BIOX
BIOX
TH
TH
Q4 25
Q3 25
Q2 25
Q1 25
-21.1%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
BIOX
BIOX
TH
TH
Q4 25
Q3 25
Q2 25
Q1 25
28.2%
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
BIOX
BIOX
TH
TH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-8.85×
2.44×
Q3 24
1.57×
Q2 24
2.13×
Q1 24
-1.78×
2.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BIOX
BIOX

Segment breakdown not available.

TH
TH

Services$40.9M56%
Hospitality And Facilities Services South$32.6M44%

Related Comparisons